fda statement bpc-157 not approved fda.gov vs. TB-500: What Patients Should Know EVEXIAS Life Sciences filing lawsuit

EVEXIAS Life Sciences filing lawsuit over peptides Big FDA review coming this July. Here's what athletes and patients should know about BPC 157, TB 500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 # The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link FDA may take an important step toward opening the peptide floodgates this week FDA panel votes to add peptides to permitted list despite opposition from agency scientists

SKU: 54821198375 · From creatorsinfotech.com